Dynavax Technologies Sets $100 Million Accelerated Stock Buyback

Dow Jones11-11
 

By Colin Kellaher

 

Dynavax Technologies said it inked a $280 million accelerated share-repurchase agreement with Goldman Sachs.

The biopharmaceutical Dynavax on Monday said it expects an initial delivery of about 6.1 million shares, representing roughly 80% of the deal, with final settlement in the first quarter.

The Emeryville, Calif., company, which has nearly 131.5 million shares outstanding and has a market capitalization topping $1.7 billion, said it is making the accelerated buyback as part of the $200 million buyback program it announced last week, adding that it will have $100 million remaining under the program.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

November 11, 2024 08:35 ET (13:35 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment